Roeland Lameris

DRS.

20142018
If you made any changes in Pure these will be visible here soon.

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2014 2018

Improving CLL Vγ9Vδ2-T-cell fitness for cellular therapy by ex vivo activation and ibrutinib

de Weerdt, I., Hofland, T., Lameris, R., Endstra, S., Jongejan, A., Moerland, P. D., de Bruin, R. C. G., Remmerswaal, E. B. M., Ten Berge, I. J. M., Liu, N., van der Stelt, M., Faber, L. M., Levin, M-D., Eldering, E., Tonino, S. H., de Gruijl, T. D., van der Vliet, H. J. & Kater, A. P., 22 Nov 2018, In : Blood. 132, 21, p. 2260-2272 13 p.

Research output: Contribution to journalArticleAcademicpeer-review

A bispecific nanobody approach to leverage the potent and widely applicable tumor cytolytic capacity of Vγ9Vδ2-T cells

de Bruin, R. C. G., Veluchamy, J. P., Lougheed, S. M., Schneiders, F. L., Lopez-Lastra, S., Lameris, R., Stam, A. G., Sebestyen, Z., Kuball, J., Molthoff, C. F. M., Hooijberg, E., Roovers, R. C., Santo, J. P. D., van Bergen en Henegouwen, P. M. P., Verheul, H. M. W., de Gruijl, T. D. & van der Vliet, H. J., 17 Oct 2017, (Accepted/In press) In : OncoImmunology.

Research output: Contribution to journalArticleAcademicpeer-review

Generation and characterization of CD1d-specific single-domain antibodies with distinct functional features

Lameris, R., de Bruin, R. C. G., Henegouwen, P. M. P. V. B. E., Verheul, H. M., Zweegman, S., de Gruijl, T. D. & van der Vliet, H. J., Sep 2016, In : Immunology. 149, 1, p. 111-121

Research output: Contribution to journalArticleAcademicpeer-review

Bispecific antibody platforms for cancer immunotherapy

Lameris, R., de Bruin, R. C. G., Schneiders, F. L., Henegouwen, P. M., Verheul, H. M. W., de Gruijl, T. D. & van der Vliet, H. J., 2014, In : Critical Reviews in Oncology / Hematology. 92, 3, p. 153-165

Research output: Contribution to journalArticleAcademicpeer-review